Financial Performance Study Of Beta Pharmaceutical Based On EVA

For a long time,China’s chemical drugs are mainly generic drugs.Different from generic drugs,innovative drugs are difficult to develop and have more investment.Compared with the generic drug market that is saturated,the market potential of innovative drugs is greater.At present,there is still a large gap in the demand for innovative drugs in China.Due to the increasing demand for clinical innovative drugs in the anti-cancer and anti-tumor market,it is difficult for China’s current medical insurance system to burden it in the long term,so it is imperative to vigorously develop the development of innovative drugs.The financial performance evaluation of an enterprise is a scientific and effective method to measure the effect of cost control and capital use management of an enterprise,which can help the management to fully understand the operation status of the enterprise,timely find the deficiencies in the operation and management,so as to improve the value of the enterprise.As a representative enterprise among the innovative pharmaceutical enterprises,its financial performance research is helpful for us to grasp the development law of the industry,improve the financial performance level of the enterprise,and realize the sustainable development of the enterprise.In this paper,Beta Pharmaceutical Co.,Ltd.was selected as the research object.On the basis of the relevant research results of scholars at home and abroad,the financial performance and EVA theories are used to evaluate the financial performance,find out the shortcomings of the enterprise according to the evaluation results,and put forward corresponding suggestions for improvement.This paper consists of five parts,Firstly,the purpose and significance and the relevant theoretical research on EVA at home and abroad;next,Introduced the relevant concepts and theoretical basis of financial performance and EVA,Lay a theoretical foundation for the financial performance analysis later on;third,The basic information of Beta Pharmaceutical,And the use of the traditional financial indicators for its financial analysis and evaluation,Find the four deficiencies in traditional financial performance,And to analyze the necessity and feasibility of the application of EVA;fourth,The EVA-based financial performance evaluation of Beta Pharmaceutical,In the calculation of the indicators,Adjust the accounting items according to the adjustment principle,And through the comparative analysis with the traditional financial performance,Find and present the problems in the financial performance of Beta Pharmaceutical,Including the capital structure needs to be optimized,the low efficiency of capital use and the lack of EVA-based incentive mechanism;last,For the problems existing in the financial performance,Relevant countermeasures and suggestions from optimizing the capital structure,improving the efficiency of capital use and constructing EVA performance incentive mechanism,To improve the company’s operating performance and financial position.